Specific therapeutic options for transthyretin amyloidosis
The epidemiology of systemic amyloidosis has recently undergone a spectacular transformation. While light-chain amyloidosis remains a rare disease with a stable incidence, chronic inflammatory disease associated amyloidosis (AA) is diagnosed less frequently, the incidence of the mutational and wild-...
Saved in:
Main Author: | Zoltán Pozsonyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Promenade Kft
2024-12-01
|
Series: | Cardiologia Hungarica |
Subjects: | |
Online Access: | https://cardiologia.hungarica.eu/archive/2024-issues/2024-6-contents/specific-therapeutic-options-for-transthyretin-amyloidosis?article=open |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Cardiac Amyloidosis in Patients Undergoing Echocardiography at a Tertiary Center
by: Jonathan D. Knott, MD, et al.
Published: (2025-03-01) -
Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01) -
Unusual hypertrophic cardiomyopathy: case report of an early onset wild-type ATTR amyloidosis accompanied by a chromosomal duplication involving the MYH6 and MYH7 gene
by: Jassin Hamidi, et al.
Published: (2025-02-01) -
Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
by: Katrine Bay, et al.
Published: (2022-06-01) -
Hereditary transthyretin amyloidosis incidentally diagnosed by video-associated lung surgery for lung cancer: A case report
by: Katsuhiro Itogawa, et al.
Published: (2025-01-01)